Supplements

Is Losing Words Mid-Sentence Normal with Fibroids?

Losing words mid-sentence with fibroids isn't in your head — it's in your blood, your hormones, and your stress axis. Iron-deficiency anemia from heavy bleeding, estrogen dominance, and chronically elevated cortisol all suppress the same brain regions responsible for verbal retrieval. Understanding which mechanism is driving yours is the first step toward fixing it.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·9 min read
fibroidsword finding difficultybrain fogiron deficiencyestrogen dominancecortisol
Is Losing Words Mid-Sentence Normal with Fibroids?

Is Losing Words Mid-Sentence Normal with Fibroids?

Yes, for many people with fibroids — particularly those with heavy periods. Chronic blood loss depletes iron, and iron-deficiency anemia is one of the most well-documented causes of cognitive slowing, word-finding difficulty, and verbal processing gaps. Hormonal imbalances (especially high estrogen relative to progesterone) compound the effect. It's not a neurological disease; it's a physiological load your body is struggling to carry.

---

Why Fibroids Can Affect Your Brain, Not Just Your Uterus

Uterine fibroids are benign tumors of the uterine wall, but their downstream effects extend well beyond the pelvis. The most direct route to cognitive symptoms is iron-deficiency anemia. Fibroids are the leading cause of heavy menstrual bleeding in reproductive-age women, and prolonged heavy bleeding steadily depletes ferritin and hemoglobin. When hemoglobin drops, less oxygen reaches the brain — and the brain responds with fatigue, slowed processing speed, and difficulty retrieving words mid-thought.

A systematic review published in Nutrients confirmed that iron deficiency — even without frank anemia — impairs attention, working memory, and verbal learning in adults (Falkingham et al., Nutrients 2010; PMID: 22254109). The finding matters because many people with fibroids sit in the "iron-deficient but not yet anemic" zone for months or years before anyone checks their ferritin. Serum ferritin can fall to 10–20 ng/mL — territory associated with measurable cognitive impairment — while hemoglobin remains technically "normal." Clinicians often miss it because they order a CBC without ordering ferritin separately.

The mechanism at the cellular level is well established. Iron is a cofactor for tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis. Dopamine is central to working memory, attention, and the smooth retrieval of words from long-term memory. When iron is depleted, dopamine synthesis drops, and the prefrontal cortex loses one of its primary neuromodulators. A 2014 randomized controlled trial in iron-deficient (non-anemic) women found that eight weeks of iron supplementation significantly improved verbal learning and attention compared to placebo — effect sizes in the range of 0.4–0.6 standard deviations on composite cognitive scores (Murray-Kolb & Beard, American Journal of Clinical Nutrition 2007; PMID: 17284748). The study used 60 mg elemental iron daily; the cognitive benefit tracked closely with the rise in serum ferritin.

Beyond iron, fibroids disrupt the hormonal environment. They are estrogen-sensitive tumors that both respond to and promote higher circulating estrogen levels. Estrogen dominance — an excess of estrogen relative to progesterone — has been associated with brain fog, mood instability, and verbal retrieval difficulty. Progesterone, by contrast, has neuroprotective and GABA-modulating effects that support cognitive clarity. Allopregnanolone, a progesterone metabolite, is one of the most potent endogenous positive allosteric modulators of GABA-A receptors in the brain. When progesterone falls relative to estrogen, allopregnanolone drops with it, and the inhibitory tone that keeps anxiety and cognitive noise in check weakens. When that balance tips, cognitive symptoms follow.

Chronic pain from fibroid pressure also chronically activates the hypothalamic-pituitary-adrenal (HPA) axis, flooding the body with cortisol. Sustained high cortisol damages hippocampal neurons involved in memory consolidation and word retrieval (Lupien et al., Nature Reviews Neuroscience 2009; PMID: 19229242). In a study of adults with chronically elevated salivary cortisol, hippocampal volume was inversely correlated with cumulative cortisol exposure — and smaller hippocampal volume predicted worse verbal memory performance independently of age or education. So you may be dealing with three simultaneous hits to cognition: low iron, hormonal imbalance, and stress-driven cortisol elevation.

---

Can Severe Anxiety Actually Make You Lose Words Mid-Sentence?

Absolutely — and this is one of the most underappreciated mechanisms in the fibroid conversation. Anxiety is deeply intertwined with hormonal conditions like perimenopause, and fibroids often drive estrogen fluctuations that directly trigger anxiety symptoms. When anxiety reaches moderate-to-severe intensity, it consumes working memory resources that your brain would otherwise devote to language production.

The prefrontal cortex (PFC) — the region most responsible for word retrieval and organized speech — is exquisitely sensitive to the neurochemical environment. High circulating cortisol and norepinephrine during anxious states literally suppress PFC activity, a mechanism documented in primate and human neuroimaging research (Arnsten, Nature Reviews Neuroscience 2009; PMID: 19654628). The result is that under significant anxiety, words you know perfectly well become temporarily inaccessible. The tip-of-the-tongue phenomenon becomes constant rather than occasional.

There is also a working memory ceiling effect worth understanding. Working memory — the mental workspace you use to hold a thought while searching for the right word — has a finite capacity. Anxiety fills a disproportionate share of that capacity with threat-monitoring and rumination, leaving less bandwidth for language. A 2007 study in Psychological Science showed that math-anxious individuals performing under pressure made more errors not because they lacked math ability, but because their working memory was being actively consumed by worry (Beilock & Carr, Psychological Science 2005; PMID: 15771869). The same dynamic applies to verbal fluency under anxiety load. The words aren't gone — the retrieval pathway is being crowded out.

This is not a sign of neurological disease. It is a sign that your nervous system is under a load it was not designed to sustain indefinitely. Managing the anxiety — not just symptom-suppressing it — typically restores verbal fluency alongside it. If you're experiencing anxiety alongside other hormonal symptoms, understanding the pattern is well-recognized across conditions like PMDD.

If you also experience word-loss linked to your menstrual cycle rather than to fibroid pain specifically, the mechanisms overlap significantly with what's seen in PMDD — where estrogen and progesterone fluctuations directly disrupt verbal memory in the luteal phase.

---

What Your Lab Work Is (and Isn't) Telling You

One of the most common sources of confusion and frustration in this situation is receiving a scan or a blood panel that comes back "normal" — and still feeling cognitively impaired. This disconnect is real and has a straightforward explanation: the tests that most commonly come back normal are not measuring the variables most relevant to your symptoms.

A pelvic ultrasound showing fibroids of modest size tells you nothing about your ferritin, your estradiol-to-progesterone ratio, your cortisol curve, or your inflammatory load. A CBC that shows hemoglobin of 11.8 g/dL may not flag as clinically anemic, yet functional cognitive impairment from relative iron deficiency can precede anemia by months. The NIH Office of Dietary Supplements notes that iron deficiency is the most common nutritional deficiency worldwide and that the brain is among the first organs to show functional changes as stores decline — even before hematological markers shift.

Similarly, a standard metabolic panel won't capture estrogen dominance or low progesterone. For that you typically need a Day 21 serum progesterone (or equivalent timed to the luteal peak), a sensitive estradiol assay, and ideally a four-point salivary or dried urine cortisol to assess whether the HPA axis is dysregulated across the day rather than just at a morning draw.

If your conventional workup has come back unremarkable but you still feel awful, it's worth asking specifically for ferritin (target above 50–70 ng/mL for cognitive optimization, not just above 12 for "normal"), a timed progesterone, and a cortisol curve. Why your CRP can be normal while you still feel awful is a question many people in this situation encounter — inflammatory load can be real and impactful even when standard markers appear clean.

---

The Practical Protocol: What Actually Moves the Needle

Addressing word-finding difficulty driven by fibroids requires targeting the specific mechanism that is dominant for you. Below is a framework organized by root cause.

Root CauseDiagnostic SignalIntervention Target
Iron deficiency / anemiaFerritin < 30 ng/mL, low hemoglobinElemental iron 30–60 mg daily with vitamin C; recheck ferritin at 8 weeks
Estrogen dominanceHigh estradiol relative to progesterone, luteal phase < 10 ng/mL progesteroneReduce xenoestrogen exposure; consider DIM or calcium d-glucarate under supervision
HPA axis dysregulation (high cortisol)Elevated a.m. cortisol, flat diurnal curve, poor sleepAdaptogenic support (see below); sleep hygiene; reduction of chronic inflammatory inputs
Anxiety-driven working memory depletionSubjective anxiety, rumination, hypervigilanceNervous system regulation: breathwork, therapy, magnesium, GABA-supporting compounds
Subclinical inflammationHigh-sensitivity CRP > 1.5, elevated ferritin despite low ironAnti-inflammatory dietary pattern; omega-3 fatty acids

For iron repletion, the research supports taking elemental iron on alternate days in some populations — a 2017 trial showed that alternate-day dosing produces equal or greater fractional iron absorption compared to daily dosing because hepcidin levels (which block absorption) reset overnight (Moretti et al., Blood 2015; PMID: 26289639). Taking iron with 250–500 mg of vitamin C in the same sitting further enhances non-heme iron absorption by reducing ferric iron to the more absorbable ferrous form.

For cortisol dysregulation, the most clinically studied adaptogens are ashwagandha (KSM-66 extract standardized to withanolides) and Rhodiola rosea. A 2012 double-blind RCT of 64 adults with chronic stress found that KSM-66 at 300 mg twice daily reduced serum cortisol by 27.9% and significantly improved self-reported cognitive performance over 60 days compared to placebo (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). This is one of the more robust ashwagandha trials, with biological endpoint verification rather than just subjective ratings.

For anxiety-driven PFC suppression, magnesium plays a supporting role through NMDA receptor modulation and GABAergic tone. Magnesium glycinate is typically preferred for this indication because of its superior absorption relative to oxide forms and its minimal GI burden at therapeutic doses of 300–400 mg elemental magnesium daily.

---

What This Means for Your Formula

When Ones reviews blood work and health history for someone reporting fibroid-related cognitive symptoms, the formula typically prioritizes ingredients targeting the identified root causes rather than a one-size-fits-all blend.

For iron-driven cognitive symptoms, Ones works in the context of the user's ferritin and hemoglobin picture — the AI flags low ferritin as a priority driver and may incorporate supportive micronutrients that enhance iron absorption and red blood cell metabolism, including vitamin C and B12, calibrated to the user's actual levels.

For HPA axis dysregulation showing up in cortisol or wearable-detected poor sleep recovery, KSM-66 Ashwagandha at 600 mg is included based on the Chandrasekhar trial evidence above — this is the same extract and dose used in the clinical literature, not a lower "label-claim" dose. For anxiety-mediated cognitive interference, Magnesium Glycinate dosed to 300–400 mg elemental and Rhodiola Rosea (standardized to 3% rosavins, 1% salidroside) address both the GABAergic and dopaminergic sides of the equation. Ones doesn't supplement iron directly in capsule form — that requires clinical oversight — but the platform will flag low ferritin as something to address with your provider and build complementary micronutrient support around it.

The formula is built from your specific data, not from a generic "brain health" protocol. That distinction matters when several mechanisms may be operating simultaneously.

---

Key Takeaways

  • Word-finding difficulty with fibroids is common and mechanistically explained — it is not early dementia or neurological disease in the vast majority of cases.
  • Iron deficiency is the most direct and correctable driver: even sub-anemic ferritin levels impair dopamine synthesis and verbal memory; target ferritin above 50–70 ng/mL, not just the lab's lower reference limit.
  • Estrogen dominance and low progesterone suppress the GABAergic tone that keeps the brain calm and verbally fluent; hormonal assessment requires timed testing, not just a spot estrogen draw.
  • Anxiety consumes working memory capacity that would otherwise support word retrieval — this is a measurable neurological mechanism, not a psychological weakness.
  • Standard labs frequently miss the relevant variables: request ferritin, luteal-phase progesterone, and a diurnal cortisol curve if your CBC and pelvic ultrasound came back "normal" but symptoms persist.
  • The practical protocol is root-cause-specific: iron repletion, adaptogenic cortisol support at clinical doses, and GABAergic magnesium are evidence-based starting points — but the right combination depends on which mechanisms are actually driving your symptoms.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading